High plasma CD40 ligand level is associated with more advanced stages and worse prognosis in colorectal cancer

Figure 3 Change in plasma CD40 ligand level and platelet count with the course of colorectal cancer within those patients who had all three laboratory measurements (mean ± SD). A: CD40 ligand level; B: Platelet count. n = 30. For the platelet count, a significant decrease could be observed (P < 0.0001), while the CD40 ligand level of patients did not change with the course of the disease (P = 0.6813). The red dot and thick line represent mean and median values, respectively. CRC: Colorectal cancer.